logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

The probability of the Federal Reserve cutting interest rates by 25 basis points in January next year is 19.9%.

date
23/12/2025
According to CME "Fed Watch": The probability of the Fed cutting rates by 25 basis points in January 2026 is 19.9%, maintaining rates unchanged at 44.7%, the probability of keeping rates unchanged is 47.1%, and the probability of cumulative rate cuts of 50 basis points is 8.2%.
Latest
3 m ago
Galaxy Securities: Continue to be optimistic about the configuration value of the banking sector.
3 m ago
Asian assets "counterattack": Asia-Pacific stock markets outperform Europe and the United States for the first time in five years, institutions predict that stocks, bonds, and exchange rates will continue to shine in 2026.
4 m ago
Gold prices hit a record high, boosted by escalating geopolitical risks.
5 m ago
Huatai Securities: The EU tariffs are temporarily suspended, but the trend of tire giants going overseas remains unchanged.
5 m ago
Fosun Pharma (02196.HK) responds to the acquisition of Green Valley Pharmaceuticals: Mannitol sodium capsules confirmed clinical research has been recognized by the drug regulatory center, with a cumulative enrollment of 580 cases.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.